Active, not recruitingPhase 1NCT05974579

Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Université de Sherbrooke
Principal Investigator
Eric E Turcotte, MD
Estrie University Integrated Health and Social Services Center - University Hospital of Sherbrooke
Intervention
89Zr-DFO-AP-101(drug)
Enrollment
12 target
Eligibility
18 years · All sexes
Timeline
2023 – 2025

Study locations (1)

Collaborators

Eli Lilly and Company · Chorus Wellness Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05974579 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis →

← Back to all trials